Dehydroepiandrosterone and its metabolites: Differential effects on androgen receptor trafficking and transcriptional activity

Journal of Steroid Biochemistry and Molecular Biology

Volumn 99, Issue 1, 2006, Pages 50-58

  Mo, Qianxing ^a   Lu, Shi fang ^a   Simon, Neal G ^a  

^a LEHIGH UNIVERSITY   (United States)

Author keywords

7 OH DHEA; 7 OH DHEA; 7 oxo DHEA; Androgen receptor; Androstenediol; Androstenedione; DHEA; DHEA S; Intracellular trafficking

Indexed keywords

7 BETA DEHYDROEPIANDROSTERONE; 7 OXODEHYDROEPIANDROSTERONE; ANDROGEN RECEPTOR; ANDROSTENEDIOL; ANDROSTENEDIONE; GREEN FLUORESCENT PROTEIN; METHIONYLMETHIONYLTHREONYLVALYLALANYLARGINYLGLUTAMYLCYSTEINYLALANYL THREONINE; PEPTIDE; PRASTERONE; PRASTERONE SULFATE; UNCLASSIFIED DRUG;

ANDROGEN SYNTHESIS; ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HORMONAL REGULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; TRANSCRIPTION INITIATION;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DEHYDROEPIANDROSTERONE; GENES, REPORTER; INTRACELLULAR FLUID; PROTEIN TRANSPORT; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; RODENTIA;

EID: 33646102678     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.11.011     Document Type: Article

References (43)

1. Compagnone N.A., and Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21 (2000) 1-56
2. Cameron D.R., and Braunstein G.D. The use of dehydroepiandrosterone therapy in clinical practice. Treat Endocrinol. 4 2 (2005) 95-114
3. Labrie F. Adrenal androgens and intracrinology. Semin. Reprod. Med. 22 4 (2004) 299-309
4. Nawata H., Yanase T., Goto K., Okabe T., Nomura M., Ashida K., and Watanabe T. Adrenopause. Horm. Res. 62 Suppl. 3 (2004) 110-114
5. Arlt W., and Hewison M. Hormones and immune function: implications of aging. Aging Cell 3 4 (2004) 209-216
6. Baulieu E.E., Thomas G., Legrain S., Lahlou N., Roger M., Debuire B., Faucounau V., Girard L., Hervy M.P., Latour F., Leaud M.C., Mokrane A., Pitti-Ferrandi H., Trivalle C., de Lacharriere O., Nouveau S., Rakoto-Arison B., Souberbielle J.C., Raison J., Le Bouc Y., Raynaud A., Girerd X., and Forette F. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHE age study to a sociobiomedical issue. Proc. Natl. Acad. Sci. U.S.A. 97 8 (2000) 4279-4284
7. Martel C., Sourla A., Pelletier G., Labrie C., Fournier M., Picard S., Li S., Stojanovic M., and Labrie F. Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat. J. Endocrinol. 157 3 (1998) 433-442
8. Villareal D.T. Effects of dehydroepiandrosterone on bone mineral density: what implications for therapy?. Treat Endocrinol. 1 6 (2002) 349-357
9. Arlt W., Callies F., van Vlijmen J.C., Koehler I., Reincke M., Bidlingmaier M., Huebler D., Oettel M., Ernst M., Schulte H.M., and Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N. Engl. J. Med. 341 14 (1999) 1013-1020
10. Karishma K.K., and Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci. 16 3 (2002) 445-453
11. Strous R.D. Dehydroepiandrosterone (DHEA) augmentation in the management of schizophrenia symptomatology. Essent. Psychopharmacol. 6 3 (2005) 141-147
12. van Broekhoven F., and Verkes R.J. Neurosteroids in depression: a review. Psychopharmacology (Berl.) 165 2 (2003) 97-110
13. Flood J.F., Farr S.A., Johnson D.A., Li P.K., and Morley J.E. Peripheral steroid sulfatase inhibition potentiates improvement of memory retention for hippocampally administered dehydroepiandrosterone sulfate but not pregnenolone sulfate. Psychoneuroendocrinology 24 8 (1999) 799-811
14. Vallee M., Mayo W., and Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res. Brain Res. Rev. 37 1-3 (2001) 301-312
15. Wolf O.T. Cognitive functions and sex steroids. Ann. Endocrinol. (Paris) 64 2 (2003) 158-161
16. Galderisi S., Mucci A., Monteleone P., Sorrentino D., Piegari G., and Maj M. Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids. Biol. Psychiatry 53 10 (2003) 921-927
17. Huppert F.A., and Van Niekerk J.K. Dehydroepiandrosterone (DHEA) supplementation for cognitive function. Cochrane Database Syst. Rev. 2 (2001) CD000304
18. Racchi M., Balduzzi C., and Corsini E. Dehydroepiandrosterone (DHEA) and the aging brain: flipping a coin in the "fountain of youth". CNS Drug Rev. 9 1 (2003) 21-40
19. Wolkowitz O.M., Kramer J.H., Reus V.I., Costa M.M., Yaffe K., Walton P., Raskind M., Peskind E., Newhouse P., Sack D., De Souza E., Sadowsky C., and Roberts E. DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology 60 7 (2003) 1071-1076
20. Labrie F. Extragonadal synthesis of sex steroids: intracrinology. Ann. Endocrinol. (Paris) 64 2 (2003) 95-107
21. Legrain S., and Girard L. Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects. Drugs Aging 20 13 (2003) 949-967
22. Dhatariya K.K., and Nair K.S. Dehydroepiandrosterone: is there a role for replacement?. Mayo Clin. Proc. 78 10 (2003) 1257-1273
23. Lu S.F., Mo Q., Hu S., Garippa C., and Simon N.G. Dehydroepiandrosterone upregulates neural androgen receptor level and transcriptional activity. J. Neurobiol. 57 2 (2003) 163-171
24. Mo Q., Lu S., Hu S., and Simon N.G. DHEA and DHEA sulfate differentially regulate androgen receptor and its transciptional activity. Mol. Brain Res. 126 (2004) 165-172
25. Gatto V., Aragno M., Gallo M., Tamagno E., Martini A., Di Monaco M., Brignardello E., and Boccuzzi G. Dehydroepiandrosterone inhibits the growth of DMBA-induced rat mammary carcinoma via the androgen receptor. Oncol. Rep. 5 (1998) 214-243
26. Gordon C.M., Grace E., Emans S.J., Feldman H.A., Goodman E., Becker K.A., Rosen C.J., Gundberg C.M., and LeBoff M.S. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J. Clin. Endocrinol. Metab. 87 11 (2002) 4935-4941
27. Hammond J., Le Q., Goodyer C., Gelfand M., Trifiro M., and LeBlanc A. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J. Neurochem. 77 5 (2001) 1319-1326
28. Marwah A., Marwah P., and Lardy H. Ergosteroids VII: perchloric acid-induced transformations of 7-oxygenated steroids and their bio-analytical applications-liquid chromatographic-mass spectrometric study. Bioorg. Chem. 30 (2002) 233-248
29. Cui H., Lin S.Y., and Belsham D.D. Evidence that dehydroepiandrosterone, DHEA, directly inhibits GnRH gene expression in GT1-7 hypothalamic neurons. Mol. Cell Endocrinol. 203 1-2 (2003) 13-23
30. Jellinck P.H., Lee S.J., and McEwen B.S. Metabolism of dehydroepiandrosterone by rat hippocampal cells in culture: possible role of aromatization and 7-hydroxylation in neuroprotection. J. Steroid. Biochem. Mol. Biol. 78 4 (2001) 313-317
31. Jellinck P.H., Crof G., McEwen B.S., Gottfried-Blackmore A., Jones G., Byford V., and Bulloch K. Metabolism of dehydroepiandrosterone by rodent brain cell lines: relationship between 7-hydroxylation and aromatization. J. Sterod. Biochem. Mol. Biol. 93 (2005) 81-86
32. Labrie C., Belanger A., and Labrie F. Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 123 3 (1988) 1412-1417
33. Mitamura K., Nakagawa T., Shimada K., Namiki M., Koh E., Mizokami A., and Honma S. Identification of dehydroepiandrosterone metabolites formed from human prostate homogenate using liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry. J. Chromatogr. A 961 1 (2002) 97-105
34. Buvat J. Androgen therapy with dehydroepiandrosterone. World J. Urol. 21 5 (2003) 346-355
35. Lu S., Simon N., McKenna S., Nau G., and Cologer-Clifford A. Neural androgen receptor: sex differences and similarities in autoregulation. Endocrinology (Baltimore) 139 (1998) 1594-1601
36. Sourla A., Martel C., Labrie C., and Labrie F. Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland. Endocrinology 139 2 (1998) 753-764
37. Culig Z., Hobisch A., Cronauer M.V., Cato A.C., Hittmair A., Radmayr C., Eberle J., Bartsch G., and Klocker H. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol. Endocrinol. 7 12 (1993) 1541-1550
38. Tan J., Sharief Y., Hamil K.G., Gregory C.W., Zang D.Y., Sar M., Gumerlock P.H., deVere White R.W., Pretlow T.G., Harris S.E., Wilson E.M., Mohler J.L., and French F.S. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol. Endocrinol. 11 4 (1997) 450-459
39. Ahlbom E., Prins G.S., and Ceccatelli S. Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res. 892 2 (2001) 255-262
40. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., and Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A 95 4 (1998) 1852-1857
41. Zwain I.H., and Yen S.S. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140 (1999) 3843-3852
42. Akwa Y., Morfin R.F., Robel P., and Baulieu E.E. Neurosteroid metabolism. 7alpha-Hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes. Biochem. J. 288 (1992) 959-964
43. Mizokami A., Koh E., Fujita H., Maeda Y., Egawa M., Koshida K., Honma S., Keller E.T., and Namiki M. The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor. Cancer Res. 64 2 (2004) 765-771